发明名称 |
ADOPTIVE IMMUNOTHERAPY WITH ENHANCED T LYMPHOCYTE SURVIVAL |
摘要 |
The invention provides for compositions, e.g., pharmaceutical compositions, comprising a T lymphocyte, or a population thereof, expressing at least one recombinant polynucleotide encoding a cytokine that enhances T lymphocyte survival during the contraction phase of an immune response. The invention further provides an isolated T lymphocyte, or population thereof, expressing at least one recombinant polynucleotide encoding the cytokine, wherein the polynucleotide comprises a non-native coding sequence encoding the cytokine. Also provided is the use of such compositions and T lymphocytes, or populations thereof, for the treatment or prevention of a medical condition e.g., cancer. A method of preparing the a T lymphocyte with enhanced T cell survival is further provided herein. |
申请公布号 |
WO2007037780(A3) |
申请公布日期 |
2007.08.23 |
申请号 |
WO2005US36407 |
申请日期 |
2005.10.07 |
申请人 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES;MORGAN, RICHARD, A.;ROSENBERG, STEVEN, A.;HSU, CARY |
发明人 |
MORGAN, RICHARD, A.;ROSENBERG, STEVEN, A.;HSU, CARY |
分类号 |
C12N5/0783 |
主分类号 |
C12N5/0783 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|